Table 3.

Age and gender distribution of patients with PMR and RS3PE

Age	(A) Patients	(B) PMR	(B/A) (%)	(C) RS3PE	(C/A) (%)
Male
0–	44	0		0
10–	166	0		0
20–	471	0		0
30–	479	0		0
40–	299	0		0
50–	406	0		0
60–	440	2	0.45	0
70–	389	1	0.26	2	0.51
80–	141	0		1	0.71
0–49	1,459	0		0
50–	1,376	3	0.22	3	0.22
Overall	2,835	3	0.11	3	0.11
Female
0–	22	0		0
10–	232	0		0
20–	692	0		0
30–	687	0		0
40–	430	0		0
50–	593	2	0.34	0
60–	589	1	0.17	0
70–	530	3	0.57	0
80–	258	1	0.39	0
0–49	2,062	0		0
50–	1,971	7	0.36	0
Overall	4,033	7	0.17	0
Both
0–49	3,521	0		0
50–	3,347	10	0.30	3	0.09
Total	6,868	10	0.15	3	0.04